ALLG, in 2024, continues its five decades of impact – Australasian Leukaemia and Lymphoma Group

Australasian Leukaemia & Lymphoma Group shared a post on LinkedIn.

“ALLG, in 2024, continues its five decades of impact.
With 6 new blood cancer trials opening in NZ and Australia, we can pursue further research for patients requiring better treatments, better lives.

Working collaboratively with our valued partners both locally and globally, our ultimate aim is to find a cure for this devastating disease.

Our collaborations with European colleagues like Prof Uwe Platzbecker (pictured with Delaine Smith and Prof Judith Trotman) enable us to bring important research to Australia and New Zealand. Visit us to find out more.”

Source: Australasian Leukaemia and Lymphoma Group/LinkedIn